Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Schwann cells and their transcriptional network: Evolution of key regulators of peripheral myelination.
Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses.
Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway.
The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort.
Human endogenous retroviruses in neurologic disease.
Transient global amnesia revealing multiple sclerosis.
Thrombotic processes in multiple sclerosis as manifestation of innate immune activation.
Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis.
The development of primary central nervous system B-cell lymphoma in multiple sclerosis.
Deep brain stimulation for pain.
Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine.
Non-protein amino acids and neurodegeneration: The enemy within.
Microglia and neuroprotection.
Synthesis and Evaluation of Fluorinated Fingolimod (FTY720) Analogues for Sphingosine-1-Phosphate Receptor Molecular Imaging by Positron Emission Tomography.
The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients.
Nitric oxide plays a dual role in the oxidative injury of cultured rat microglia but not astroglia.
Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.
Effect of a self-management and follow-up program on self-efficacy in patients with multiple sclerosis: a randomized clinical trial.
Simultaneous Determination of Oxysterols, Cholesterol and 25-Hydroxy-Vitamin D3 in Human Plasma by LC-UV-MS.
Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis.
A Case of Acute Disseminated Encephalomyelitis in a Middle-Aged Adult.
[Symptomatic therapy in multiple sclerosis].
The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia.
White and gray matter damage in primary progressive MS: The chicken or the egg?
Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases.
Pages
« first
‹ previous
…
553
554
555
556
557
558
559
560
561
…
next ›
last »